REAL · Insider Trading
The RealReal, Inc. Common Stock
Every open-market purchase and sale reported by REAL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Karen Katz | Director | A | +2,262 | — |
| 2026-10-01 | Mark McCaffrey | Director | A | +1,414 | — |
| 2026-08-24 | Steve Ming Lo | Chief Accounting Officer | Sell | −12,559 | −$137.79K |
| 2026-08-24 | Gopal Ajay Madan | Chief Financial Officer | Sell | −36,418 | −$399.87K |
| 2026-08-24 | Levesque Rati Sahi | Chief Executive Officer | Sell | −84,432 | −$927.06K |
| 2026-08-24 | Todd A Suko | Chief Legal Officer and Secret | Sell | −17,567 | −$192.78K |
| 2026-08-24 | Luke Thomas Friang | Chief Product & Tech Officer | Sell | −22,028 | −$241.87K |
| 2026-07-29 | Jennifer McKeehan | Director | A | +14,150 | — |
| 2026-07-29 | Mark McCaffrey | Director | A | +14,150 | — |
| 2026-07-29 | James R. Miller | Director | A | +14,150 | — |
| 2026-07-29 | Robert J Krolik | Director | A | +14,150 | — |
| 2026-07-29 | Caretha Coleman | Director | A | +14,150 | — |
| 2026-07-29 | Karen Katz | Director | A | +14,150 | — |
| 2026-07-01 | Karen Katz | Director | A | +1,378 | — |
| 2026-07-01 | Mark McCaffrey | Director | A | +742 | — |
| 2026-05-22 | Luke Thomas Friang | Chief Product & Tech Officer | Sell | −21,183 | −$195.94K |
| 2026-05-22 | Todd A Suko | Chief Legal Officer and Secret | Sell | −17,353 | −$160.52K |
| 2026-05-22 | Gopal Ajay Madan | Chief Financial Officer | Sell | −35,023 | −$323.96K |
| 2026-05-22 | Steve Ming Lo | Chief Accounting Officer | Sell | −12,077 | −$111.71K |
| 2026-05-22 | Levesque Rati Sahi | Chief Executive Officer | Sell | −81,194 | −$751.04K |
| 2026-04-14 | Steve Ming Lo | Chief Accounting Officer | A | +31,310 | — |
| 2026-04-14 | Jennifer McKeehan | Director | A | +4,247 | — |
| 2026-04-02 | Mark McCaffrey | Director | A | +963 | — |
| 2026-04-02 | Karen Katz | Director | A | +1,988 | — |
| 2026-03-20 | Gopal Ajay Madan | Chief Financial Officer | Sell | −51,585 | −$479.22K |
| 2026-02-24 | Levesque Rati Sahi | Chief Executive Officer | MIXED | +58,292 | −$1.30M |
| 2026-02-24 | Todd A Suko | Chief Legal Officer and Secret | MIXED | +17,761 | −$492.55K |
| 2026-02-24 | Gopal Ajay Madan | Chief Financial Officer | MIXED | +74,800 | −$336.40K |
| 2026-02-24 | Steve Ming Lo | Chief Accounting Officer | Sell | −16,962 | −$181.83K |
| 2026-02-24 | Luke Thomas Friang | Chief Product & Tech Officer | MIXED | +52,594 | −$210.21K |
| 2026-01-07 | Karen Katz | Director | A | +1,107 | — |
| 2026-01-07 | Niki Leondakis | Director | A | +554 | — |
| 2025-12-09 | Steve Ming Lo | Chief Accounting Officer | Sell | −62,355 | −$896.42K |
| 2025-11-28 | Gopal Ajay Madan | Chief Financial Officer | Sell | −28,520 | −$420.01K |
| 2025-11-28 | Todd A Suko | Chief Legal Officer and Secret | Sell | −72,933 | −$1.03M |
| 2025-11-28 | Steve Ming Lo | Chief Accounting Officer | Sell | −59,789 | −$864.25K |
| 2025-11-21 | Gopal Ajay Madan | Chief Financial Officer | Sell | −30,196 | −$394.36K |
| 2025-11-21 | Luke Thomas Friang | Chief Product & Tech Officer | Sell | −18,619 | −$243.16K |
| 2025-11-21 | Steve Ming Lo | Chief Accounting Officer | Sell | −22,426 | −$292.88K |
| 2025-11-21 | Todd A Suko | Chief Legal Officer and Secret | Sell | −31,611 | −$412.84K |
| 2025-11-21 | Levesque Rati Sahi | Chief Executive Officer | Sell | −97,036 | −$1.27M |
| 2025-11-20 | Todd A Suko | Chief Legal Officer and Secret | Sell | −75,693 | −$1.07M |
| 2025-11-19 | Gilbert L. Baird III | Director | Sell | −7,686,442 | −$101.54M |
| 2025-11-14 | Steve Ming Lo | Chief Accounting Officer | MIXED | — | −$89.78K |
| 2025-10-23 | Mark McCaffrey | Director | A | +11,900 | — |
| 2025-10-01 | Niki Leondakis | Director | A | +823 | — |
| 2025-10-01 | Karen Katz | Director | A | +1,528 | — |
| 2025-08-22 | Gopal Ajay Madan | Chief Financial Officer | D | −31,688 | −$242.10K |
| 2025-08-22 | Levesque Rati Sahi | Chief Executive Officer | D | −101,830 | −$777.98K |
| 2025-08-22 | Luke Thomas Friang | Chief Product & Tech Officer | D | −19,538 | −$149.27K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Levesque Rati Sahi | Chief Executive Officer | 1,552,989 | $20.22M |
| Gopal Ajay Madan | Chief Financial Officer | 1,108,860 | $14.44M |
| Chatelle Aileen Lynch | Chief People Officer | 613,577 | $7.99M |
| Todd A Suko | Chief Legal Officer and Secret | 592,090 | $7.71M |
| Luke Thomas Friang | Chief Product & Tech Officer | 519,677 | $6.77M |
| Caretha Coleman | Director | 265,933 | $3.46M |
| Karen Katz | Director | 256,145 | $3.34M |
| Niki Leondakis | Director | 207,489 | $2.70M |
| Robert J Krolik | Director | 205,507 | $2.68M |
| James R. Miller | Director | 198,066 | $2.58M |
| Steve Ming Lo | Chief Accounting Officer | 178,317 | $2.32M |
| John E Koryl | Chief Executive Officer | 68,170 | $887.57K |
| Mark McCaffrey | Director | 29,169 | $379.78K |
| Gilbert L. Baird III | Director | 26,025 | $338.85K |
| Jennifer McKeehan | Director | 18,397 | $239.53K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the REAL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.